Oruka Therapeutics Stock Forecast

Stock Price Forecast

The 10 analysts with 12-month price forecasts for Oruka Therapeutics stock have an average target of 52.7, with a low estimate of 40 and a high estimate of 75. The average target predicts an increase of 60.52% from the current stock price of 32.83.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$40	$52.7	$48	$75
Change	+21.84%	+60.52%	+46.21%	+128.45%

* Price targets were last updated on Jan 13, 2026.

Analyst Ratings

The average analyst rating for Oruka Therapeutics stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	5	5	6	6	7	7
Buy	2	3	3	4	4	3
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	8	9	10	11	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Martin Fan Wedbush	Wedbush	Buy Maintains $42 → $45	Buy	Maintains	$42 → $45	+37.07%	Jan 13, 2026
Julian Harrison BTIG	BTIG	Strong Buy Maintains $63 → $73	Strong Buy	Maintains	$63 → $73	+122.36%	Jan 12, 2026
Michael Yee UBS	UBS	Strong Buy Initiates $50	Strong Buy	Initiates	$50	+52.30%	Jan 7, 2026
Yasmeen Rahimi Piper Sandler	Piper Sandler	Buy Initiates $75	Buy	Initiates	$75	+128.45%	Dec 18, 2025
Roger Song Jefferies	Jefferies	Strong Buy Initiates $45	Strong Buy	Initiates	$45	+37.07%	Nov 13, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-2.18

from -4.23

EPS Next Year

-2.59

from -2.18

Fiscal Year	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029	FY 2030
Period Ending	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029	Dec 31, 2030
Revenue	-	-	-	-	-	-	21.25M
Revenue Growth	-	-	-	-	-	-	-
EPS	-4.23	-2.18	-2.59	-2.81	-3.48	-3.93	-4.39
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	14	14	10	5	6	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026
High	-2.00	-2.25
Avg	-2.18	-2.59
Low	-2.60	-3.35

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.